HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
GDI1
GDP dissociation inhibitor 1
Chromosome X Β· Xq28
NCBI Gene: 2664Ensembl: ENSG00000203879.13HGNC: HGNC:4226UniProt: A0A0S2Z3X8
129PubMed Papers
21Diseases
0Drugs
15Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
midbodyGDP-dissociation inhibitor activitypositive regulation of toll-like receptor signaling pathwayprotein bindingX-linked non-syndromic intellectual disabilityX-linked intellectual disability, Siderius typenon-syndromic X-linked intellectual disabilitygenetic disorder
✦AI Summary

GDI1 (GDP dissociation inhibitor 1) is an X-linked gene encoding a regulatory protein that controls small GTPase activity, particularly Rab proteins involved in vesicle trafficking. GDI1 functions by inhibiting GDP dissociation from Rab proteins and promoting their extraction from membranes in the inactive GDP-bound state 1. This regulation is critical for intracellular transport processes including synaptic vesicle trafficking and axonal transport 2. GDI1 mutations cause X-linked intellectual developmental disorder 41, characterized by selective cognitive impairment affecting short-term temporal associations and memory formation 3. Gdi1-knockout mice display deficits in associative memory with altered social behavior, suggesting the gene's role in forebrain functions 3. Recent evidence reveals that GDI1 loss impairs working memory through dysregulated astrocyte glycolysis, providing a novel neuroglial mechanism for neurodevelopmental disease 4. Elevated GDI1 emerges as a biomarker for neurodegenerative disease: it is elevated in cerebrospinal fluid of frontotemporal dementia and Alzheimer's disease patients, differentiating amyloid-positive from amyloid-negative individuals 5. Paradoxically, GDI1 inhibition attenuates Ξ²-amyloid-induced neurotoxicity in Alzheimer's models 6. Additionally, RAB3A hyperphosphorylation in Parkinson's disease pathogenesis disrupts GDI1 binding, impairing synaptic vesicle precursor trafficking 7.

Sources cited
1
GDI1 extracts Rac1 from liposomes preferentially in GDP-bound state and is prevented by GTP-binding and effector interaction
PMID: 25014207
2
Gdi1-deficient mice show impaired short-term temporal association memory and altered social behavior
PMID: 12354782
3
GDI1 is involved in vesicle trafficking as part of synaptic vesicle cycling disorders causing neurodevelopmental phenotypes
PMID: 32738165
4
Gdi1 deletion in astrocytes causes working memory impairment that is rescued by glycolysis inhibition
PMID: 33309713
5
GDI1 is elevated in cerebrospinal fluid of FTD and AD patients and differentiates amyloid-positive from amyloid-negative MCI cases
PMID: 37775827
6
GDI1 is elevated in serum and cells in AD, and GDI1 inhibition attenuates Ξ²-amyloid-induced neurotoxicity
PMID: 38013121
7
RAB3A hyperphosphorylation in LRRK2-associated Parkinson's disease disrupts binding to GDI1 and motor adaptors
PMID: 38512027
Disease Associationsβ“˜21
X-linked non-syndromic intellectual disabilityOpen Targets
0.74Strong
X-linked intellectual disability, Siderius typeOpen Targets
0.46Moderate
non-syndromic X-linked intellectual disabilityOpen Targets
0.46Moderate
genetic disorderOpen Targets
0.45Moderate
Intellectual disabilityOpen Targets
0.37Weak
Alzheimer diseaseOpen Targets
0.35Weak
multiple sclerosisOpen Targets
0.34Weak
neurodegenerative diseaseOpen Targets
0.34Weak
Parkinson diseaseOpen Targets
0.34Weak
lysosomal storage diseaseOpen Targets
0.34Weak
colorectal carcinomaOpen Targets
0.08Suggestive
neoplasmOpen Targets
0.04Suggestive
cardiac hypertrophyOpen Targets
0.04Suggestive
hypertensionOpen Targets
0.02Suggestive
non-alcoholic steatohepatitisOpen Targets
0.02Suggestive
cancerOpen Targets
0.02Suggestive
acute myeloid leukemiaOpen Targets
0.02Suggestive
colorectal cancerOpen Targets
0.02Suggestive
breast cancerOpen Targets
0.02Suggestive
internet addiction disorderOpen Targets
0.01Suggestive
Intellectual developmental disorder, X-linked 41UniProt
Pathogenic Variants15
NM_001493.3(GDI1):c.442del (p.Ala148fs)Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2025β†’ Residue 148
NM_001493.3(GDI1):c.1088_1089insT (p.Glu363fs)Pathogenic
Intellectual disability, X-linked 41
β˜…β˜†β˜†β˜†2024β†’ Residue 363
NM_001493.3(GDI1):c.1267C>T (p.Arg423Cys)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 423
NM_001493.3(GDI1):c.706del (p.Gln236fs)Likely pathogenic
Intellectual disability, X-linked 41
β˜…β˜†β˜†β˜†2022β†’ Residue 236
NM_001493.3(GDI1):c.706C>T (p.Gln236Ter)Likely pathogenic
Intellectual disability, X-linked 41
β˜…β˜†β˜†β˜†2022β†’ Residue 236
NM_001493.3(GDI1):c.45+1G>ALikely pathogenic
Intellectual disability, X-linked 41|Ovarian serous cystadenocarcinoma
β˜…β˜†β˜†β˜†2022
NM_001493.3(GDI1):c.1173_1174insACATGAT (p.Asp392delinsThrTer)Pathogenic
Intellectual disability|Intellectual disability, X-linked 41
β˜…β˜†β˜†β˜†2020β†’ Residue 392
NM_001493.3(GDI1):c.788del (p.Gly263fs)Likely pathogenic
Intellectual disability, X-linked 41
β˜…β˜†β˜†β˜†2019β†’ Residue 263
NM_001493.3(GDI1):c.819+1G>ALikely pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2017
NM_001493.3(GDI1):c.473T>C (p.Phe158Ser)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2015β†’ Residue 158
GRCh38/hg38 Xq28(chrX:154348522-154594454)x3Pathogenic
Intellectual disability, X-linked 41
β˜†β˜†β˜†β˜†2024
NM_001493.3(GDI1):c.1060_1064del (p.Ser354fs)Pathogenic
Intellectual disability, X-linked 41
β˜†β˜†β˜†β˜†2019β†’ Residue 354
NM_001493.3(GDI1):c.1186_1187del (p.Ser396fs)Pathogenic
Intellectual disability, X-linked 41
β˜†β˜†β˜†β˜†2011β†’ Residue 396
NM_001493.3(GDI1):c.1268G>C (p.Arg423Pro)Pathogenic
Intellectual disability, X-linked 41
β˜†β˜†β˜†β˜†1998β†’ Residue 423
NM_001493.3(GDI1):c.208C>T (p.Arg70Ter)Pathogenic
Intellectual disability, X-linked 41
β˜†β˜†β˜†β˜†1998β†’ Residue 70
View on ClinVar β†—
Related Genes
RAB5CProtein interaction99%RAB8BProtein interaction99%RAB31Protein interaction98%RAB11BProtein interaction98%RAB5AProtein interaction97%RAB10Protein interaction96%
Tissue Expression6 tissues
Brain
100%
Ovary
44%
Lung
32%
Heart
28%
Bone Marrow
25%
Liver
19%
Gene Interaction Network
Click a node to explore
GDI1RAB5CRAB8BRAB31RAB11BRAB5ARAB10
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt P31150
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.15Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.03 [0.01–0.15]
RankingsWhere GDI1 stands among ~20K protein-coding genes
  • #3,620of 20,598
    Most Researched129 Β· top quartile
  • #2,444of 5,498
    Most Pathogenic Variants15
  • #205of 17,882
    Most Constrained (LOEUF)0.15 Β· top 5%
Genes detectedGDI1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls.
PMID: 37775827
Mol Neurodegener Β· 2023
1.00
2
Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in mice.
PMID: 12354782
Hum Mol Genet Β· 2002
0.90
3
Liposome reconstitution and modulation of recombinant prenylated human Rac1 by GEFs, GDI1 and Pak1.
PMID: 25014207
PLoS One Β· 2014
0.80
4
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors.
PMID: 38512027
J Cell Biol Β· 2024
0.70
5
The neurodevelopmental spectrum of synaptic vesicle cycling disorders.
PMID: 32738165
J Neurochem Β· 2021
0.60